NPR News Now
NPR News Now

NPR News: 04-27-2026 7AM EDT

6h ago4:40794 words
0:000:00

NPR News: 04-27-2026 7AM EDTSee pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

Transcript

EN

"Live from NPR News in Washington.

in their investigation into the shooting this weekend at the White House correspondent's

dinner. The suspect in the attack, 31-year-old Cole Allen, is expected to appear in

federal court today in Washington, D.C. And beer's Ryan Lucas has more." "Shots were fired Saturday night at the Hilton Hotel where President Trump and other administration officials were attending the White House correspondent's dinner. Authorities say the suspect Cole Allen had tried to rush past security and storm the ballroom where the event was taking place. Officials say Allen was armed with guns and knives. Investigators have

been scrambling to collect evidence since the incident. Acting Attorney General Todd Blanc says preliminary information indicates the suspect was targeting members of the Trump

administration. Ryan Lucas and PR News, Washington."

President Trump says he wants to see the White House correspondent's dinner go forward. He spoke to CBS's 60 minutes last night. "I want them because I don't want to see it be canceled. I don't want to have a crazy person.

I think it's really bad for a crazy person to be able to cancel something like this."

Trump says he wants the dinner to be rescheduled within 30 days. The chair of the White House correspondent's association says the group's board will meet to assess what happened and determine how to proceed. Britain's King Charles and Queen Camilla are scheduled to arrive in the U.S. today for a state visit. British officials say despite the attempt at a attack on the press dinner over the weekend, the meetings will go ahead as planned. The monarch's

visit comes as ties between the two countries are strained. President Trump has criticized Britain for not joining U.S. military action against Iran. President Trump has also repeatedly denigrated U.K. Prime Minister Kierstarmer. Two big tech titans open a legal battle in federal court today in Oakland, California. Billionaire Elon Musk is suing the artificial intelligence

company he helped create "open AI." It's run by Sam Altman. Musk is demanding changes

at Open AI. From Member Station KQED, Rachel Myro reports, damages could reach $134 billion.

Elon Musk's claim, Sam Altman dropped his promise to serve humanity in favor of profit. Open AI says this lawsuit is about Musk trying to crash a rival that's grown from a research lab into a nearly trillion dollar giant. Musk is asking the court to reverse a decade of growth, Charlie Bullock at the Institute for Law and AI says that's easier said than done. There are ways that you could unscramble this omelet, but it would be extremely difficult and

extremely complicated and have very serious consequences and it would be a massive headache for everyone involved. Over the next month, expect spicy testimony under oath from two of the most powerful men in Silicon Valley. For NPR News, I'm Rachel Myro. This is NPR. Iran's foreign minister is in Moscow for meetings with Russian leaders. He's also visited Pakistan and Oman, but the vital street of Hormuz remains blocked both by Iran and by the U.S. military.

That's cutting off vital crude oil supplies from much of the world. The most advanced attempt to use gene editing to modify a gene inside the human body appears highly effective for treating a rare but potentially fatal genetic disorder. NPR's Rob Stein has the story. The treatment involves a rare genetic condition called hereditary angiodema. The condition causes repeated sometimes life-threatening swelling attacks in various parts of the body. Researchers

infused the CRISPR gene editing tool into the livers of 52 patients to knock out a gene causing the condition and found the gene editing reduced the swelling attacks by 87%. The approach is noteworthy because it does not involve removing cells from the body editing them in the lab and infusing the edited cells back into the body. Based on the results, the company is asking the food and drug administration to approve the treatment. Rob Stein and Pernus.

Climbers in Nepal who are trying to summit Mount Everest are still held up. A huge ice chunk has fallen into their path. Skilled mountaineers say they are waiting for the ice to melt before the climbers can continue. The skilled mountaineers need to go ahead and lay the route, set up, and secure ladders. I'm Korvakulman, NPR News. Every episode of NPR's It's Bene Minute Podcast starts with a question about how culture

shapes our lives. How are we spending too much on other people's weddings? Is social media bad for your mental health? We're here for your right to be curious. One big question at a time. Follow its Bene Minute wherever you get your podcasts.

Compare and Explore